Skip to main content
. Author manuscript; available in PMC: 2018 Oct 15.
Published in final edited form as: J Immunol. 2017 Sep 15;199(8):2885–2895. doi: 10.4049/jimmunol.1700870

Figure 3. MHV-68 infection differentially modulates FM cytokine/chemokine responses to LPS.

Figure 3

Human FM explants were treated with no treatment (NT), LPS (100ng/ml), MHV-68 (1.5×104/ml PFU) or both MHV-68 and LPS (n=4); Supernatants were measured by multiplex analysis. *p<0.05 relative to the NT control unless otherwise indicated. Data are expressed as mean±SEM.